Estrogen therapy avoidance possible factor in nearly 50,000 deaths

07/22/2013 | HealthDay News · CBS News

A study published in the American Journal of Public Health found that avoidance of estrogen hormonal therapy was a possible factor in the deaths of almost 50,000 women who had hysterectomies and experienced menopausal symptoms over the past decade. Researchers analyzed U.S. Census data and found that the use of hormone therapy fell significantly after the publication of the 2002 U.S. Women's Health Initiative Study, which linked estrogen-progestin combination therapy to higher risk of breast cancer, heart disease, stroke and blood clots. "Sadly, the media, women, and health care providers did not appreciate the difference between [estrogen-only and estrogen-plus-progestin] hormone therapy," said health expert Dr. Philip Sarrel.

View Full Article in:

HealthDay News · CBS News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
Washington DC, DC